Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001193125-26-111100

Chief Financial Officer acquired 1,376 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fuhrman Alan · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-13 Grant or award : show line 1 in the form +1,376 $9.13 $12,562 16,164 D
Loading xslF345X05/ownership.xml…